BioSpace News Archive

Biotech Bay

UK Border Force Deploys Agilent Resolve Handheld Raman Systems for Hazardous Material Detection

Agilent Technologies Inc. announced that UK Border Force is now using Resolve

July 19, 2018
·
1 min read
Biotech Bay

Arcadia Biosciences and Shriram Bioseed Reach Milestone in Developing Extended Shelf Life Tomatoes

Arcadia Biosciences, Inc. and Shriram Bioseed announced the achievement of a key milestone in developing Extended Shelf Life (ESL) tomatoes.

July 19, 2018
·
4 min read
Business

cultivate(MD) Funds Announce Investments Into Happe Spine

Genesis Innovation Group, LLC, announces the formation of HAPPE Spine LLC as well as investments by cultivate(MD) Capital Fund I, LLC and cultivate(MD) Capital Fund II, LP into HAPPE Spine.

July 19, 2018
·
3 min read
IBM Watson IoT Accelerates Business Transformation in Europe

More European companies select IBM Watson IoT across industries to improve operations and increase service to customers

July 19, 2018
·
4 min read
Business

West Celebrates Official Opening of New Global Manufacturing Facility in Waterford, Ireland and the launch of Westar® Select Component Offering

West Pharmaceutical Services, Inc. announced the official opening of its new Waterford, Ireland facility

July 19, 2018
·
5 min read
Business

Danaher Announces Plan To Spin Off Dental Business Into An Independent, Publicly Traded Company

Danaher Corporation announced its intention to spin off its Dental segment into an independent, publicly-traded company

July 19, 2018
·
7 min read
Business

Innovus Pharma Signs Purchase Agreement with CVS Pharmacy, Inc. to Sell Its Product Androferti® to Increase Sperm Quality in Their Newly Established In-Store Men’s Clinic

CVS Men’s Health Clinic Pilot Program to Promote Androferti® in 12 to 20 Stores with the Potential, if Successful, to Expand Nationwide and Add Additional Products

July 19, 2018
·
4 min read
Drug Development

AVEO Oncology Issues Statement Regarding Revised TIVO-3 Trial Guidance

AVEO Oncology today issued the following statement regarding its recently revised guidance on the timing of topline data from the TIVO-3 study, its Phase 3 trial of tivozanib as a third-line treatment for advanced renal cell carcinoma.

July 19, 2018
·
5 min read
Deals

Concordia International Corp. Announces NASDAQ Delisting

Concordia previously announced delisting notice on May 31, 2018

July 19, 2018
·
6 min read
Genetown

IFM Therapeutics, LLC Launches Subsidiary, IFM Tre, with $31 Million Series A Financing to Develop NLRP3 Antagonists for Inflammatory Diseases

Subsidiary responsible for clinical development of NLRP3 antagonist portfolio with lead candidate expected in the clinic in 2019

July 19, 2018
·
4 min read